Southwood Research, a Propharma Group company, focuses on unlocking the potential of new medicines and bringing them to the patients who need them. We deliver excellence in execution of the projects we are involved with, and bring a flexible expertise to our clients. Therapeutic areas Therapeutic areas include Haematology / Oncology, General Medicine, Infectious Diseases, Orphan / Ultra Orphan Diseases. Clinical Research Design and successful implementation of clinical programmes for regulatory approval and product differentiation across all phase of development Regulatory Affairs Submissions strategy and management, including Market authorization filings, paediatric investigation plans, orphan strategy and submissions, label extensions and variations Drug Safety and Risk Management Development of Risk Management Plans, including risk minimisation materials. Design and implementation of post authorisation safety studies (PASS) and analysis of results Real World Evidence and Outcomes Research Integration of traditional prospective data, with data from electronic health records or other secondary data sources. Production of cost-effective data that can demonstrate a product’s effectiveness and value.
Southwood Research, a Propharma Group company, focuses on unlocking the potential of new medicines and bringing them to the patients who need them. We deliver excellence in execution of the projects we are involved with, and bring a flexible expertise to our clients. Therapeutic areas Therapeutic areas include Haematology / Oncology, General Medicine, Infectious Diseases, Orphan / Ultra Orphan Diseases. Clinical Research Design and successful implementation of clinical programmes for regulatory approval and product differentiation across all phase of development Regulatory Affairs Submissions strategy and management, including Market authorization filings, paediatric investigation plans, orphan strategy and submissions, label extensions and variations Drug Safety and Risk Management Development of Risk Management Plans, including risk minimisation materials. Design and implementation of post authorisation safety studies (PASS) and analysis of results Real World Evidence and Outcomes Research Integration of traditional prospective data, with data from electronic health records or other secondary data sources. Production of cost-effective data that can demonstrate a product’s effectiveness and value.
Company Information
- Industry
- Biotechnology
- Company Type
- Privately Held
- Founded
- 2016
- Employee Range
- 1-10
- Revenue Range
- Not available
Location
- Address
- 31-33 Chalfont Road, Buckinghamshire Seer Green, Nr Beaconsfield
- City
- Region
- Postal Code
- HP9 2QP
- Country
